{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[10,2,10,3],[11,2,11,3],[12,2,12,3],[13,2,13,3],[14,2,14,3],[15,2,15,3],[19,2,19,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910970047603321"]
[null,null,"Titolo",null,"Emerging infections : microbial threats to health in the United States / / Joshua Lederberg, Robert E. Shope, and Stanley C. Oaks, Jr., editors"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academy Press, 1992"]
[null,null,"ISBN",null,"9786610196333"]
[{"$nulls":4},"9781280196331"]
[{"$nulls":4},"1280196335"]
[{"$nulls":4},"9780309584630"]
[{"$nulls":4},"0309584639"]
[{"$nulls":4},"9780585020150"]
[{"$nulls":4},"0585020159"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (308 p.)"]
[null,null,"Disciplina",null,"614.4/273"]
[null,null,"Soggetti",null,"Emerging infectious diseases - United States"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Committee on Emerging Microbial Threats to Health, Division of Health Sciences Policy, Division of International Health, Institute of Medicine.\""]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (p. 170-191) and index."]
[null,null,"Nota di contenuto",null,"EMERGING INFECTIONS -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- RECOGNITION -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- Public Education and Behavioral Change -- 1 Background -- PLAGUE -- INFLUENZA -- OPTIMISM AND INDIFFERENCE -- Sanitation and Hygiene -- Quarantine -- Smallpox -- Poliomyelitis -- TROUBLE AHEAD -- Lyme Disease -- Peptic Ulcer -- Malaria -- Dengue -- Tuberculosis -- NEXT STEPS -- 2 Factors in Emergence -- THE CONCEPT OF EMERGENCE -- HUMAN DEMOGRAPHICS AND BEHAVIOR -- Population Growth, Density, and Distribution -- DENGUE -- Immunosuppression -- Sexual Activity and Substance Abuse -- TECHNOLOGY AND INDUSTRY -- Modern Medicine -- HEALTH CARE DELIVERY -- PREVENTION OF NOSOCOMIAL INFECTIONS -- Food Processing and Handling -- AGRICULTURAL CONDITIONS AND PRACTICES -- FOOD PROCESSING AND PRESERVATION TECHNOLOGIES -- DEMOGRAPHICS -- CONSUMER ATTITUDES AND BEHAVIOR -- COMMERCE -- DIET AND FOOD PREPARATION -- Trichinosis -- Anisakiasis -- Water Treatment -- ECONOMIC DEVELOPMENT AND "]
[{"$nulls":4},"LAND USE -- Dam Building and Rift Valley Fever -- Reforestation and Lyme Disease -- Global Warming -- INTERNATIONAL TRAVEL AND COMMERCE -- Travel -- MALARIA -- Commerce -- HANTAAN AND RELATED HANTAVIRUSES -- THE FILOVIRUSES -- MICROBIAL ADAPTATION AND CHANGE -- Natural Variation/Mutation -- RNA VIRUSES -- Influenza A Virus -- Human Immunodeficiency Virus -- DNA VIRUSES -- Hepatitis B Virus -- BACTERIA -- Brazilian Purpuric Fever -- Selective Pressure and the Development of Resistance -- RESISTANCE TO ANTIBIOTICS -- Pneumococci -- Staphylococci and Enterococci -- Pseudomonas aeruginosa -- Mycobacterium tuberculosis -- RESISTANCE TO ANTIVIRALS -- Acyclovir and Herpes Simplex Virus."]
[{"$nulls":4},"Zidovudine and Human Immunodeficiency Virus-1 -- RESISTANCE TO ANTIMALARIALS -- VECTOR RESISTANCE TO PESTICIDES -- New Understandings: Microbes as Cofactors in Chronic Disease -- HUMAN T-CELL LEUKEMIA VIRUS TYPES I AND II -- ATHEROSCLEROSIS -- HUMAN PAPILLOMAVIRUS -- BREAKDOWN OF PUBLIC HEALTH MEASURES -- Inadequate Sanitation: Cholera -- Complacency -- INADEQUATE LEVELS OF IMMUNIZATION: MEASLES -- War -- 3 Addressing the Threats -- RECOGNITION -- Surveillance in Action: The World Health Organization's Smallpox Eradication Program -- LESSONS FROM THE SMALLPOX EXPERIENCE -- Current U.S.-Supported Surveillance Efforts -- DOMESTIC EFFORTS -- Notifiable Diseases Surveillance -- Nosocomial Infections Surveillance -- Outbreak Surveillance -- Influenza Surveillance -- Access to Surveillance Information -- INTERNATIONAL EFFORTS -- Past Successes -- Loss of Capacity -- Current Efforts -- Multilateral International Surveillance Efforts -- WORLD HEALTH ORGANIZATION -- PAN AMERICAN HEALTH ORGANIZATION -- The Concept of Global Surveillance -- INTERVENTION -- The U.S. Public Health System -- Research and Training -- THE ROCKEFELLER FOUNDATION -- NATIONAL INSTITUTES OF HEALTH -- CENTERS FOR DISEASE CONTROL -- DEPARTMENT OF DEFENSE -- OTHER PROGRAMS -- Vaccine and Drug Development -- VACCINES -- ANTIMICROBIAL DRUGS -- Vector Control -- VECTOR-CONTROL RESOURCES -- PESTICIDES FOR VECTOR CONTROL -- Public Education and Behavioral Change -- References -- Appendixes -- A Task Forces -- TASK FORCE 1 -- Bacteria, Rickettsiae, and Chlamydiae -- TASK FORCE 2 -- Viruses -- TASK FORCE 3 -- Protozoans, Helminths, and Fungi -- TASK FORCE 4 -- Policy Options -- TASK FORCE 5 -- Recommendations -- B Catalog of Emerging Infectious Disease Agents -- EMERGENT BACTERIA, RICKETTSIAE, AND CHLAMYDIAE -- Aeromonas -- Borrelia burgdorferi -- Campylobacter jejuni."]
[{"$nulls":4},"Chlamydia pneumoniae (TWAR Strain) -- Chlamydia trachomatis -- Clostridium difficile -- Ehrlichia chaffeensis -- Escherichia coli O157:H7 -- Haemophilus influenzae biogroup aegyptius -- Helicobacter pylori -- Legionella pneumophila -- Listeria monocytogenes -- Mycobacterium tuberculosis -- Staphylococcus aureus (and Toxic Shock Syndrome) -- Streptococcus pyogenes (Group A) -- Vibrio cholerae -- Vibrio vulnificus -- EMERGENT VIRUSES -- Bovine Spongiform Encephalopathy Agent -- California Serogroup Viruses (LaCrosse, Jamestown Canyon, California Encephalitis) -- Chikungunya Virus -- Crimean-Congo Hemorrhagic Fever Virus -- Dengue Virus -- Filoviruses (Marburg, Ebola) -- Hantaviruses (Hantaan, Puumala, and Seoul) -- Hepatitis B Virus -- Hepatitis C Virus -- Hepatitis E Agent -- Human Herpesvirus-6 -- Human Immunodeficiency Virus (HIV), Types 1 and 2 -- Human Papillomavirus (HPV) -- Human Parvovirus B19 -- Human T-Cell Leukemia Virus (HTLV), Types 1 and 2 -- Influenza A "]
[{"$nulls":4},"Virus -- Japanese Encephalitis Virus -- Lassa Virus -- Measles Virus -- Norwalk and Norwalk-like Agents -- Rabies Virus -- Rift Valley Fever Virus -- Ross River Virus -- Rotavirus -- Venezuelan Equine Encephalitis (VEE) Virus -- Yellow Fever Virus -- EMERGENT PROTOZOANS, HELMINTHS, AND FUNGI -- Anisakis -- Babesia -- Candida -- Crytococcus -- Cryptosporidium -- Giardia lamblia -- Microsporidia -- Plasmodium -- Pneumocystis carinii -- Strongyloides stercoralis -- Toxoplasma gondii -- C Global Resources for Infectious Disease Surveillance -- U.S. and U.S. Affiliated -- U.S. Department of Defense -- Public Health Service -- International -- World Health Organization, Geneva, Switzerland -- Pasteur Institutes -- D Committee and Staff Biographies -- COMMITTEE -- STAFF -- Glossary -- Acronyms and Abbreviations -- Index."]
[null,null,null,"Sommario/riassunto","The emergence of HIV disease and AIDS, the reemergence of tuberculosis, and the increased opportunity for disease spread through international travel demonstrate the critical importance of global vigilance for infectious diseases. This volume highlights risk factors for the emergence of microbial threats to health, warns against complacency in public health, and promotes early prevention as a cost-effective and crucial strategy for maintaining public health in the United States and worldwide. The volume identifies infectious disease threats posed by bacteria and viruses, as well as protozoans, helminths, and fungi. Rich in information, it includes a historical perspective on infectious disease, with focuses on Lyme disease, peptic ulcer, malaria, dengue, and recent increases in tuberculosis. The panel discusses how \"new\" diseases arise and how \"old\" ones resurge and considers the roles of human demographics and behavior, technology and industry, economic development and land use, international travel and commerce, microbial adaptation and change, and breakdown of public health measures in changing patterns of infectious disease. Also included are discussions and recommendations on disease surveillance; vaccine, drug, and pesticide development; vector control; public education and behavioral change; research and training; and strengthening of the U.S. public health system. This volume will be of immediate interest to scientists specializing in all areas of infectious dieseases and microbiology, healthy policy specialists, public health officials, physicians, and medical faculty and students, as well as anyone interested in how their health can be threatened by infectious diseases."]